Novartis's total assets for Q2 2025 were $104.39B, an increase of 4.46% from the previous quarter. NVS total liabilities were $62.34B for the fiscal quarter, a 1.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.